The cervical intervertebral disc has the ability to absorb a huge compressive load while providing a range of motion between the bones in the neck. Market players have developed several artificial intervertebral cervical discs and used them to treat cervical disc problems. Artificial cervical disc replaces the movement and cushioning function of damaged cervical disc.
Medtronic and Globus Medical, Inc.- Notable Market Players in Artificial Cervical Intervertebral Disc Market
Leading companies operating in the artificial cervical intervertebral disc market have undertaken various organic and inorganic growth strategies. The artificial cervical intervertebral disc market majorly comprises of Zimmer Biomet Holdings, Inc.; Globus Medical, Inc.; Centinel Spine, LLC; Synergy Spine Solutions, Inc.; Aditus Medical; AxioMed LLC; NuVasive, Inc.; Orthofix Medical, Inc.; Medtronic; B. Braun Melsugen AG amongst others. The companies have been implementing various strategies that have helped their growth and, in turn, brought about several breakthroughs and transitions in the industry. The companies have utilized organic strategies such as launches, and product approvals. Moreover, the market players have also deployed several utilized inorganic strategies, including mergers & acquisitions, partnerships, and collaborations.
Below are the major growth strategies undertaken by the players operating in the global artificial cervical intervertebral disc market:
| Year | News |
| Apr-2021 | NuVasive, Inc. received the approval for the NuVasive Simplify Cervical Artificial Disc (Simplify Disc) from the United States Food and Drug Administration (FDA) for two-level cTDR, resulting in the achievement of the regulatory milestone and payment of US$45.8 million. The disc demonstrated clinical superiority at 24 months compared to anterior cervical discectomy and fusion in a two-level FDA Investigational Device Exemption study. |
| Feb-2020 | Zimmer Biomet’s over 150,000 Mobi-C Cervical Discs have been implanted worldwide. It was first implanted in France in 2004 and was approved for sale in the U.S. by the FDA in 2013. Zimmer Biomet holds a commanding position in the US$200 million global cervical disc market. The Mobi-C device represents an optimal solution with statistical superiority to two-level fusion at seven years. |
| Apr-2018 | Orthofix Medical Inc. acquired Spinal Kinetics Inc., a privately held developer and manufacturer of artificial cervical and lumbar discs, namely the M6-C cervical and M6-Llumbar artificial discs used to treat patients suffering from degenerative disc disease of the spine. The M6 discs are the only FDA-approved artificial discs that mimic the anatomic structure of a natural disc into their design. |
